Gair, Gair, Conason, Rubinowitz, Bloom, Hershenhorn, Steigman & Mackauf is a New York Plaintiff's personal injury law firm specializing in automobile accidents, construction accidents, medical malpractice, products liability, police misconduct and all types of New York personal injury litigation.
Published on:

Legal Considerations Regarding Delayed Adverse Event Reporting by Medical Device Manufacturers

FDA logoAs product liability attorneys, we recognize the critical importance of timely adverse event reporting by medical device manufacturers. Such reporting is not only a regulatory obligation but also a fundamental aspect of patient safety and corporate accountability. Delayed reporting can have significant legal ramifications, including:

  1. Regulatory Non-Compliance: Manufacturers are mandated by federal law to report adverse events to the FDA within 30 days of becoming aware of them. Failure to comply can result in enforcement actions, fines, and potential injunctions against the company.
  2. Increased Liability Exposure: Delayed reporting may be construed as negligence, exposing manufacturers to lawsuits from patients harmed by undisclosed device risks. Courts may view the failure to report promptly as a breach of duty to consumers.
  3. Erosion of Public Trust: Transparency is vital in the healthcare industry. Delayed reporting can damage a company’s reputation, leading to loss of market share and diminished stakeholder confidence.

Recent Findings on Reporting Delays

A recent study published in The BMJ analyzed approximately 4.4 million adverse event reports submitted to the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database between September 2019 and December 2022. The study revealed that nearly a third of these reports were not submitted within the mandatory 30-day window, potentially hindering timely detection of patient safety issues.

Key Findings from the Study

  • On-Time Reporting: 71% of adverse events were reported within the 30-day requirement.
  • Late Reporting: 4.5% were reported between 31 and 180 days, while 9.1% were submitted after 180 days.
  • Data Issues: 15.5% of reports had missing or invalid date information.

Notably, a small group of manufacturers and devices were responsible for the majority of late reports. Specifically, three manufacturers and 13 devices accounted for over half of the delayed submissions.

Manufacturers with Notable Late Reporting

The study identified several top manufacturers with significant numbers of late reports:

  1. BD (Becton, Dickinson and Company): Their infusion pumps were among the devices with the highest number of delayed reports.
  2. Medtronic: Known for insulin pumps, they were also highlighted for late submissions.
  3. Abbott: Their glucose monitors featured prominently among devices with delayed adverse event reports.

Implications for Patient Safety

Timely reporting of adverse events is crucial for the FDA, healthcare providers, and patients to identify and mitigate potential risks associated with medical devices. Delays in reporting can lead to:

  • Delayed Risk Identification: Slower recognition of device-related hazards, potentially leading to prolonged patient exposure to unsafe devices.
  • Ineffective Regulatory Actions: Hindered ability of the FDA to promptly issue safety communications or mandate recalls.
  • Erosion of Public Trust: Reduced confidence in medical device safety and the effectiveness of regulatory oversight.

Recommendations for Improvement

To enhance the reporting system and ensure patient safety, the study’s authors suggest:

  • Stricter Enforcement: The FDA should issue warning letters and take enforcement actions against manufacturers with consistent late reporting.
  • Transparency Measures: Publishing lists of manufacturers and devices with frequent late reports to inform healthcare providers and the public.
  • Enhanced Reporting Requirements: Mandating manufacturers to include notification dates in electronic submissions to facilitate monitoring of reporting timeliness.

Conclusion

The findings from this study underscore the need for robust postmarket surveillance and stringent adherence to reporting timelines by medical device manufacturers. Prompt reporting is essential to safeguard public health and maintain trust in medical devices and regulatory processes.

Your Legal Rights and Next Steps

If you or a loved one has suffered harm due to a defective medical device, you have legal options under product liability laws. These laws allow patients to seek compensation for injuries resulting from design defects, manufacturing defects, or inadequate warnings associated with medical devices. Pursuing legal action can help cover medical expenses, lost wages, pain and suffering, and other related damages.

Given the complexities involved in such cases, consulting with experienced product liability attorneys is crucial. Our team is dedicated to advocating for patients’ rights and holding manufacturers accountable for their obligations. We encourage affected individuals and their families to reach out to our firm at 212-943-1090 to discuss their cases and explore potential legal remedies.